Unaudited Financial results for the quarter ended on June 30, 2026 is attched
RESULTS
▼ Concern Flagged
MEDIUM RISK
📅 Filed on BSE: 25 Jul 2026, 12:21 PM IST · BSE ID: 63da5638-38a2-4e66-ad4c-e47e9333007f
View Original BSE Filing (PDF)
💡
In Simple Terms
Mercury Laboratories released its latest financial report, showing its profit fell significantly compared to last year's same quarter.
🤖 AI Summary
- Mercury Laboratories reported unaudited net profit after tax of 29.78 lakhs for the quarter ended June 30, 2026.
- Total income for Q1 FY27 stood at 1,601.54 lakhs, a decrease from 1,831.64 lakhs in Q1 FY26.
- Basic and Diluted Earnings Per Share for the quarter ended June 30, 2026 was 2.48.
- The Board of Directors approved these financial results at their meeting held on July 25, 2026.
- Statutory Auditors completed a Limited Review of the unaudited financial results for the quarter.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Net Profit after Tax (Q1 FY27)
29.78 lakhs
Net Profit after Tax (Q1 FY26)
96.76 lakhs
Total Income (Q1 FY27)
1,601.54 lakhs
Total Income (Q1 FY26)
1,831.64 lakhs
Earnings Per Share (Q1 FY27)
2.48
🏢 How This Affects the Company
Net profit after tax for Q1 FY27 decreased to 29.78 lakhs from 96.76 lakhs in Q1 FY26. Total income declined to 1,601.54 lakhs compared to 1,831.64 lakhs in the prior year's comparable quarter.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required by shareholders based on this filing.
👤
Who Is Affected
All shareholders are affected as the company reported a decrease in net profit and total income for the quarter ended June 30, 2026.
🔍
Management Signal
The approval of these results signals management's formal disclosure of the company's financial performance for Q1 FY27.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Q2 FY27 results — monitor total income and net profit trends.
Changes in cost of materials consumed and other expenses in subsequent quarters.
Any further operational updates or business developments from management.
MEDIUM RISK
Significant decline in net profit and total income YoY suggests potential business challenges.
💡 Investor Takeaway
Mercury Laboratories reported a Q1 FY27 net profit after tax of 29.78 lakhs, a 69.22% decrease from 96.76 lakhs in Q1 FY26. Total income also decreased by 12.56% to 1,601.54 lakhs from 1,831.64 lakhs in the comparable prior year quarter.
⚖️ Strengths & Concerns
✅ Positives
- Other income increased to 5.22 lakhs in Q1 FY27 compared to 0.20 lakhs for Total other comprehensive income in Q1 FY26.
- Company operates in a single segment, 'Pharmaceuticals Products', providing focused business operations as per Note 4.
⚠️ Concerns
- Net Profit after Tax declined significantly to 29.78 lakhs in Q1 FY27 from 96.76 lakhs in Q1 FY26.
- Total Income decreased to 1,601.54 lakhs in Q1 FY27 from 1,831.64 lakhs in the corresponding quarter of the previous year.
📅 Company Track Record
Mercury Laboratories reported Q1 FY27 net profit of 29.78 lakhs, a 69.22% decline YoY from 96.76 lakhs in Q1 FY26. Total income also saw a decline from 1,831.64 lakhs to 1,601.54 lakhs in the same period.
Based on publicly available historical data. For context only.
❓ Frequently Asked Questions
What was Mercury Laboratories' net profit for Q1 FY27?
Mercury Laboratories reported a net profit after tax of 29.78 lakhs for the quarter ended June 30, 2026.
How did Mercury Laboratories' total income compare in Q1 FY27 to Q1 FY26?
Total income for Q1 FY27 was 1,601.54 lakhs, a decrease from 1,831.64 lakhs in the quarter ended June 30, 2025.
What was the Earnings Per Share (EPS) for Mercury Laboratories in Q1 FY27?
The Basic and Diluted Earnings Per Share for Mercury Laboratories for the quarter ended June 30, 2026, was 2.48.
When were Mercury Laboratories' Q1 FY27 results approved by the board?
The unaudited financial results for the quarter ended June 30, 2026, were approved by the Board of Directors at their meeting held on July 25, 2026.
Did the auditors review Mercury Laboratories' Q1 FY27 financial results?
Yes, the Statutory Auditors performed a 'Limited Review' of the unaudited financial results for the quarter ended June 30, 2026.
Questions based on this BSE filing only. For information purposes.